Announcement
September 14, 2021
Boston Molecules has finalized the configuration of its ZyaltTM COVID-19 IgM&IgG DR TEST kit, and will commence scaled up production
Protien Services from BM
Boston Molecules developed a novel mammalian protein platform (Z-ActiveTM) using chaperone-assisted protein expression technology to express super active cytokines and growth factors. The average protein activity is about 5-10 fold higher than competitors (R&D system, Pepro Tech. et al.)
SERVICE FEATURES
From gene to protein
- Gene synthesis
- Cloning
- Transformation
- Expression & purification
From E.coli to mammalian
- E.coli
- Yeast
- Insect
- Mammalian
High purity >97% SDS Low endotoxin
<0.10 EU per 1 μg of the protein
Quotations: Get an instant quote
Protien Services from BM
September 14, 2021
Boston Molecules developed a novel mammalian protein platform (Z-ActiveTM) using chaperone-assisted protein expression technology to express super active cytokines and
Antibody
September 14, 2021
Boston MoleculesTM is a leading custom antibody developer facilitated with cutting edge technologies and innovations. Our B-cell cloning antibody platform